Lord’s Mark Industries Ltd., a diversified healthcare and technology-led group, announced the acquisition of an

Lord’s Mark Industries Ltd.是一家多元化的医疗保健和技术主导的集团，宣布收购一家

85% stake in Renalyx Health Systems Private Limited

85%的Renalyx Health Systems私人有限公司股份

, the Bengaluru-based med-tech innovator behind India’s indigenous, AI- and cloud-enabled smart hemodialysis machine. Renalyax will serve as the R&D arm of Lords Mark Industries, driving research on advanced medical devices focused on the kidney and liver.

，总部位于班加罗尔的医疗技术革新者，印度本土研发、采用人工智能和云计算的智能血液透析机的背后推手。Renalyax将作为Lords Mark Industries的研发部门，推动以肾脏和肝脏为重点的先进医疗设备的研究。

The acquisition marks a decisive step in Lord’s Mark Industries’ expansion into next-generation medical technologies that address India’s growing burden of chronic kidney disease (CKD). Renalyx’s flagship haemodialysis machine integrates real-time remote monitoring, cloud-based clinical connectivity, and intelligent analytics, enabling hospitals, dialysis centres, and clinicians to deliver safer, more reliable, and more cost-efficient renal therapy..

此次收购标志着Lord's Mark工业公司向解决印度日益严重的慢性肾病（CKD）负担的下一代医疗技术扩展迈出了决定性的一步。Renalyx的旗舰血液透析机集成了实时远程监控、基于云的临床连接和智能分析，使医院、透析中心和临床医生能够提供更安全、更可靠且更具成本效益的肾病治疗。

With Renalyx now part of its healthcare ecosystem, Lord’s Mark Industries Ltd. is well-positioned to scale its indigenous dialysis infrastructure, enhance clinical outcomes, and expand access to quality renal care across Tier 1 to Tier 3 markets.

随着Renalyx现在成为其医疗保健生态系统的一部分，Lord’s Mark Industries Ltd. 已经为扩大其本土透析基础设施、改善临床结果，并在一线至三线市场扩展优质肾病护理的可及性做好了充分准备。

Commenting on the acquisition, Sachidanand Upadhyay, Managing Director, Lord’s Mark Industries Ltd., said

谈及此次收购，Lord’s Mark Industries Ltd.董事总经理萨奇丹南德·乌帕迪亚雅表示

: “

：“

Our investment in Renalyx is a forward-looking bet on the future of Indian healthcare, one where cutting-edge med-tech is designed, engineered, and manufactured in India for India and the world. Dialysis must move from being a high-cost, infrastructure-heavy service to a smart, connected, and patient-centric experience.

我们在Renalyx的投资是对印度医疗保健未来的一项前瞻性赌注，这是一个印度为本国和世界设计、工程和制造尖端医疗技术的未来。透析必须从高成本、基础设施密集型的服务转变为智能、互联且以患者为中心的体验。

By bringing Renalyx into our fold, we are accelerating that shift. We see this as a transformative opportunity to democratise advanced renal care, strengthen Make in India innovation, and build medical technologies that redefine accessibility and clinical excellence at scale.”.

通过将Renalyx纳入我们的体系，我们正在加速这一转变。我们认为这是一个变革性的机会，可以普及先进的肾病护理，加强“印度制造”创新，并构建重新定义大规模可及性和临床卓越的医疗技术。

Renalyx will continue to operate with its existing engineering and product teams, while leveraging Lord’s Mark Industries’ national healthcare distribution, diagnostics network, and manufacturing capabilities to drive faster market penetration and technology adoption.

Renalyx 将继续依靠其现有的工程和产品团队运营，同时利用 Lord’s Mark Industries 的全国医疗保健分销、诊断网络和制造能力，推动更快的市场渗透和技术采用。

Live Events

现场活动

Incorporated in 1998, Lord's Mark Industries Ltd. has emerged as a dynamic force in the healthcare and diagnostics sector. Building on a strong legacy of innovation, the company has strategically expanded into medical diagnostics, establishing a robust presence across the healthcare value chain.

成立于1998年的Lord's Mark Industries Ltd.在医疗保健和诊断领域崭露头角，成为一股强劲的力量。基于创新的坚实传统，公司战略性地扩展到医疗诊断领域，在整个医疗保健价值链中建立了强大的影响力。

Disclaimer: The above content is non-editorial, and TIL hereby disclaims any and all warranties, express or implied, relating to it, and does not guarantee, vouch for or necessarily endorse any of the content.

免责声明：上述内容为非编辑内容，TIL在此拒绝承担与之相关的任何及所有明示或暗示的保证，并且不保证、担保或必然认可其中的任何内容。

Add

添加

as a Reliable and Trusted News Source

作为一个可靠和值得信赖的新闻来源

Add Now!

立即添加！

(You can now subscribe to our

（你现在可以订阅我们的

Economic Times WhatsApp channel

经济时报WhatsApp频道

)

)

(You can now subscribe to our

（您现在可以订阅我们的

Economic Times WhatsApp channel

经济时报WhatsApp频道

)

)